CYNTHIA CALIXTE: Open Payments
NPI 1528300100 · SALISBURY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$739 in 26 payments from 14 companies in 2025. Trend: 2023 $322 · 2024 $555 · 2025 $739
Food & beverage: $739
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 1 | $125 |
| PFIZER INC. | 1 | $122 |
| Otsuka America Pharmaceutical, Inc. | 4 | $81 |
| Braeburn Inc. | 4 | $64 |
| Astellas Pharma US Inc | 3 | $54 |
| Indivior Inc. | 3 | $53 |
| Vanda Pharmaceuticals Inc. | 2 | $52 |
| Exact Sciences Corporation | 2 | $41 |
| SANOFI-AVENTIS U.S. LLC | 1 | $35 |
| ABBVIE INC. | 1 | $25 |
Products named: KRYSTEXXA, ABRYSVO, BRIXADI, REXULTI, Veozah, SUBLOCADE, Cologuard Collection Kit, HETLIOZ.
Industry payments across MD — which companies pay providers there.
